{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:10:38Z","timestamp":1776769838626,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The prognosis of patients with extrahepatic cholangiocarcinoma (ECCA) must be determined with precision. However, the usual TNM staging system has the drawback of ignoring age, adjuvant therapy, and gender and lacks the ability to more correctly predict patient prognosis. Therefore, we determine the risk factors of survival for patients with advanced ECCA patients and developed brand-new nomograms to forecast patients with advanced ECCA\u2019s overall survival (OS) and cancer-specific survival (CSS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Method<\/jats:title>\n                <jats:p>From the Epidemiology and End Results (SEER) database, patients with advanced ECCA were chosen and randomly assigned in a ratio of 6:4 to the training and validation subgroups. The cumulative incidence function (CIF) difference between groups was confirmed by applying Gray\u2019s and Fine test and competing risk analyses. Next, the cancer-specific survival (CSS) and overall survival (OS) nomograms for advanced ECCA were developed and validated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In accordance with the selection criteria, 403 patients with advanced ECCA were acquired from the SEER database and then split at random into two groups: a training group (<jats:italic>n<\/jats:italic>\u2009=\u2009241) and a validation group (<jats:italic>n<\/jats:italic>\u2009=\u2009162). The 1-, 2-, and 3-year cancer-specific mortality rates were 58.7, 74.2, and 78.0%, respectively, while the matching mortality rates for the competition were 10.0, 13.8, and 15.0%. Nomograms were generated for estimating OS and CSS, and they were assessed using the ROC curve and the C-index. The calibration curves showed that there was a fair amount of agreement between the expected and actual probabilities of OS and CSS. Additionally, greater areas under the ROC curve were seen in the newly developed nomograms for OS and CSS when compared to the 7th AJCC staging system. The advanced ECCA patients were divided into groupings with an elevated risk and those with a low risk and the Kaplan-Meier method was used for the survival analysis, which showed that survival time was shorter in the high-risk group than in the low-risk group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The proposed nomograms have good predictive ability. The nomograms may can help doctors determine the prognosis of patients with advanced ECCA as well as provide more precise treatment plans for them.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-023-03017-6","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T13:02:34Z","timestamp":1701349354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic model for oversurvival and tumor-specific survival prediction in patients with advanced extrahepatic cholangiocarcinoma: a population-based analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunzhong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"issue":"5","key":"3017_CR1","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.aohep.2022.100737","volume":"27","author":"A Elvevi","year":"2022","unstructured":"Elvevi A, Laffusa A, Scaravaglio M, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022;27(5):100737.","journal-title":"Ann Hepatol"},{"issue":"12","key":"3017_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/17474124.2021.1991313","volume":"15","author":"M Rimini","year":"2021","unstructured":"Rimini M, Puzzoni M, Pedica F, et al. Cholangiocarcinoma: new perspectives for new horizons. Expert Rev Gastroenterol Hepatol. 2021;15(12):1367\u201383.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"8","key":"3017_CR3","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/hep4.1730","volume":"5","author":"JD Yang","year":"2021","unstructured":"Yang JD, Ghoz H, Aboelsoud MM, et al. DNA methylation markers for detection of Cholangiocarcinoma: discovery, validation, and clinical testing in biliary brushings and plasma. Hepatol Commun. 2021;5(8):1448\u201359.","journal-title":"Hepatol Commun"},{"key":"3017_CR4","doi-asserted-by":"publisher","first-page":"1171098","DOI":"10.3389\/fonc.2023.1171098","volume":"13","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang X. An overview of extrahepatic cholangiocarcinoma: from here to where? Front Oncol. 2023;13:1171098.","journal-title":"Front Oncol"},{"issue":"9","key":"3017_CR5","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","volume":"41","author":"G Ercolani","year":"2015","unstructured":"Ercolani G, Dazzi A, Giovinazzo F, et al. Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors? Eur J Surg Oncol. 2015;41(9):1162\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"3017_CR6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/hpb.12450","volume":"17","author":"JC Mansour","year":"2015","unstructured":"Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford). 2015;17(8):691\u20139.","journal-title":"HPB (Oxford)"},{"issue":"16","key":"3017_CR7","doi-asserted-by":"publisher","first-page":"e25635","DOI":"10.1097\/MD.0000000000025635","volume":"100","author":"P Liao","year":"2021","unstructured":"Liao P, Cao L, Chen H, Pang SZ. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: a large population-based study. Medicine (Baltimore). 2021;100(16):e25635. https:\/\/doi.org\/10.1097\/MD.0000000000025635.","journal-title":"Medicine (Baltimore)"},{"key":"3017_CR8","doi-asserted-by":"publisher","first-page":"102054","DOI":"10.1016\/j.canep.2021.102054","volume":"75","author":"D Boakye","year":"2021","unstructured":"Boakye D, G\u00fcnther K, Niedermaier T, Haug U, Ahrens W, Nagrani R. Associations between comorbidities and advanced stage diagnosis of lung, breast, colorectal, and prostate cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102054.","journal-title":"Cancer Epidemiol"},{"issue":"4","key":"3017_CR9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3322\/caac.21342","volume":"66","author":"D Sarfati","year":"2016","unstructured":"Sarfati D, Koczwara B, Jackson C. The impact of comorbidity on cancer and its treatment. CA Cancer J Clin. 2016;66(4):337\u201350.","journal-title":"CA Cancer J Clin"},{"key":"3017_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ctrv.2018.02.003","volume":"64","author":"D Boakye","year":"2018","unstructured":"Boakye D, Rillmann B, Walter V, Jansen L, Hoffmeister M, Brenner H. Impact of comorbidity and frailty on prognosis in colorectal cancer patients: a systematic review and meta-analysis. Cancer Treat Rev. 2018;64:30\u20139.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"3017_CR11","doi-asserted-by":"publisher","first-page":"e065312","DOI":"10.1136\/bmjopen-2022-065312","volume":"13","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Zhang P, Huang Y, et al. Development and validation of nomograms to predict survival in patients with invasive micropapillary carcinoma of the breast. BMJ Open. 2023;13(2):e065312.","journal-title":"BMJ Open"},{"issue":"7","key":"3017_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu J, Zhang H, Li L, et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: a population-based analysis. Cancer Commun (Lond). 2020;40(7):301\u201312.","journal-title":"Cancer Commun (Lond)"},{"issue":"Suppl 1","key":"3017_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/liv.14086","volume":"39","author":"A Forner","year":"2019","unstructured":"Forner A, Vidili G, Rengo M, Bujanda L, Ponz-Sarvis\u00e9 M, Lamarca A. Clinical presentation, diagnosis and staging of cholangiocarcinoma. Liver Int. 2019;39(Suppl 1):98\u2013107.","journal-title":"Liver Int"},{"key":"3017_CR14","doi-asserted-by":"publisher","first-page":"752176","DOI":"10.3389\/fendo.2021.752176","volume":"12","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ji L, Wang X, et al. Nomogram predicts risk and prognostic factors for bone metastasis of pancreatic Cancer: a population-based analysis. Front Endocrinol (Lausanne). 2022;12:752176.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"3017_CR15","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1007\/s00268-020-05618-8","volume":"44","author":"N Golse","year":"2020","unstructured":"Golse N, Nunez J, Mazzotta A, et al. Personalized preoperative nomograms predicting postoperative risks after resection of Perihilar Cholangiocarcinoma. World J Surg. 2020;44(10):3449\u201360.","journal-title":"World J Surg"},{"issue":"23","key":"3017_CR16","first-page":"00263","volume":"S1015-9584","author":"T Zhang","year":"2023","unstructured":"Zhang T, Lai M, Wei Y, et al. Nomograms for predicting overall survival and cancer-specific survival in patients with invasive micropapillary carcinoma: based on the SEER database [published online ahead of print, 2023 mar 16]. Asian J Surg. 2023;S1015-9584(23):00263\u20134.","journal-title":"Asian J Surg"},{"issue":"7","key":"3017_CR17","doi-asserted-by":"publisher","first-page":"8050","DOI":"10.1002\/cam4.5595","volume":"12","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu C, Chen D, et al. A prognostic nomogram based on risk assessment for invasive micropapillary carcinoma of the breast after surgery. Cancer Med. 2023;12(7):8050\u201362.","journal-title":"Cancer Med"},{"issue":"6","key":"3017_CR18","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamasurg.2018.0501","volume":"153","author":"KM Doll","year":"2018","unstructured":"Doll KM, Rademaker A, Sosa JA. Practical guide to surgical data sets: surveillance, epidemiology, and end results (SEER) database. JAMA Surg. 2018;153(6):588\u20139.","journal-title":"JAMA Surg"},{"key":"3017_CR19","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3389\/fonc.2019.01329","volume":"9","author":"C He","year":"2019","unstructured":"He C, Cai Z, Zhang Y, Lin X. Prognostic model to predict Cancer-specific survival for patients with gallbladder carcinoma after surgery: a population-based analysis. Front Oncol. 2019;9:1329 Published 12 Dec 2019.","journal-title":"Front Oncol"},{"issue":"13","key":"3017_CR20","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D\u2019Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109\u201323.","journal-title":"Stat Med"},{"key":"3017_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decis Mak. 2008;8:53.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"Suppl 1","key":"3017_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/liv.14095","volume":"39","author":"SA Khan","year":"2019","unstructured":"Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: epidemiology and risk factors. Liver Int. 2019;39(Suppl 1):19\u201331.","journal-title":"Liver Int"},{"key":"3017_CR23","doi-asserted-by":"publisher","first-page":"1007538","DOI":"10.3389\/fonc.2022.1007538","volume":"12","author":"F Zhao","year":"2022","unstructured":"Zhao F, Yang D, He J, Ju X, Ding Y, Li X. Establishment and validation of a prognostic nomogram for extrahepatic cholangiocarcinoma. Front Oncol. 2022;12:1007538 Published 24 Nov 2022.","journal-title":"Front Oncol"},{"issue":"3","key":"3017_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1200\/JCO.2016.69.0834","volume":"35","author":"T Eguchi","year":"2017","unstructured":"Eguchi T, Bains S, Lee MC, et al. Impact of increasing age on cause-specific mortality and morbidity in patients with stage I non-small-cell lung Cancer: a competing risks analysis. J Clin Oncol. 2017;35(3):281\u201390.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3017_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12876-020-01464-z","volume":"20","author":"C Yu","year":"2020","unstructured":"Yu C, Zhang Y. Establishment of prognostic nomogram for elderly colorectal cancer patients: a SEER database analysis. BMC Gastroenterol. 2020;20(1):347 Published 20 Oct 2020.","journal-title":"BMC Gastroenterol"},{"issue":"9","key":"3017_CR26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jtho.2018.05.037","volume":"13","author":"S Wang","year":"2018","unstructured":"Wang S, Yang L, Ci B, et al. Development and validation of a nomogram prognostic model for SCLC patients. J Thorac Oncol. 2018;13(9):1338\u201348.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"3017_CR27","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1007\/s10620-018-5262-6","volume":"63","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Kang TU, Swan H, et al. Incidence and prognosis of subsequent Cholangiocarcinoma in patients with hepatic resection for bile duct stones. Dig Dis Sci. 2018;63(12):3465\u201373.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"3017_CR28","doi-asserted-by":"publisher","first-page":"833","DOI":"10.21037\/jgo-21-543","volume":"13","author":"Z Yu","year":"2022","unstructured":"Yu Z, Liu Q, Liao H, et al. Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. J Gastrointest Oncol. 2022;13(2):833\u201346.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"3017_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/00000658-199901000-00010","volume":"229","author":"M Kayahara","year":"1999","unstructured":"Kayahara M, Nagakawa T, Ohta T, et al. Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg. 1999;229(1):76\u201383.","journal-title":"Ann Surg"},{"issue":"5","key":"3017_CR30","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","volume":"245","author":"ML DeOliveira","year":"2007","unstructured":"DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245(5):755\u201362.","journal-title":"Ann Surg"},{"issue":"7","key":"3017_CR31","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1245\/s10434-023-13361-2","volume":"30","author":"J Sakata","year":"2023","unstructured":"Sakata J, Takizawa K, Miura K, et al. Rational extent of regional lymphadenectomy and the prognostic impact of the number of positive lymph nodes for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2023;30(7):4306\u201317. https:\/\/doi.org\/10.1245\/s10434-023-13361-2.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"3017_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00108-016-0128-5","volume":"57","author":"L Zender","year":"2016","unstructured":"Zender L, Malek NP. Diagnostik und Therapie des cholangiozellul\u00e4ren Karzinoms [diagnostics and treatment of cholangiocellular carcinoma]. Internist (Berl). 2016;57(12):1191\u2013205.","journal-title":"Internist (Berl)"},{"issue":"1","key":"3017_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.6004\/jnccn.2011.0005","volume":"9","author":"PL Greenberg","year":"2011","unstructured":"Greenberg PL, Attar E, Bennett JM, et al. NCCN clinical practice guidelines in oncology: myelodysplastic syndromes. J Natl Compr Cancer Netw. 2011;9(1):30\u201356.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"9935","key":"3017_CR34","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet. 2014;383(9935):2168\u201379.","journal-title":"Lancet"},{"key":"3017_CR35","doi-asserted-by":"publisher","first-page":"868034","DOI":"10.3389\/fonc.2022.868034","volume":"12","author":"N Wang","year":"2022","unstructured":"Wang N, Huang A, Kuang B, Xiao Y, Xiao Y, Ma H. Progress in radiotherapy for Cholangiocarcinoma. Front Oncol. 2022;12:868034 Published 2022 Apr 14.","journal-title":"Front Oncol"},{"issue":"1","key":"3017_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12957-021-02445-6","volume":"19","author":"J Lv","year":"2021","unstructured":"Lv J, Liu YY, Jia YT, et al. A nomogram model for predicting prognosis of obstructive colorectal cancer. World J Surg Oncol. 2021;19(1):337 Published 2021 Dec 2.","journal-title":"World J Surg Oncol"},{"key":"3017_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jbo.2018.09.012","volume":"13","author":"K Song","year":"2018","unstructured":"Song K, Song J, Chen F, Lin K, Ma X, Jiang J. Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients. J Bone Oncol. 2018;13:106\u201313 Published 2018 Oct 4.","journal-title":"J Bone Oncol"},{"issue":"7","key":"3017_CR38","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1245\/s10434-020-09362-0","volume":"28","author":"Z Zuo","year":"2021","unstructured":"Zuo Z, Zhang G, Song P, et al. Survival nomogram for stage IB non-small-cell lung Cancer patients, based on the SEER database and an external validation cohort. Ann Surg Oncol. 2021;28(7):3941\u201350.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"3017_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.ejso.2020.01.016","volume":"46","author":"SH Tella","year":"2020","unstructured":"Tella SH, Kommalapati A, Yadav S, et al. Novel staging system using carbohydrate antigen (CA) 19-9 in extra-hepatic cholangiocarcinoma and its implications on overall survival. Eur J Surg Oncol. 2020;46(5):789\u201395.","journal-title":"Eur J Surg Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-03017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-023-03017-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-023-03017-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T13:03:28Z","timestamp":1701349408000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-023-03017-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3017"],"URL":"https:\/\/doi.org\/10.1186\/s12876-023-03017-6","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"5 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The datasets generated and analyzed during the current study are available in the SEER database (), ethical approval was not allowed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"422"}}